Aeras Global TB Vaccine Foundation Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aeras Global TB Vaccine Foundation's estimated annual revenue is currently $11.8M per year.(i)
  • Aeras Global TB Vaccine Foundation's estimated revenue per employee is $155,000

Employee Data

  • Aeras Global TB Vaccine Foundation has 76 Employees.(i)
  • Aeras Global TB Vaccine Foundation grew their employee count by 4% last year.

Aeras Global TB Vaccine Foundation's People

NameTitleEmail/Phone
1
Head Aeras AsiaReveal Email/Phone
2
Clinical DirectorReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Senior Clinical Director & Office Lead, Aeras AfricaReveal Email/Phone
5
Senior Research AssociateReveal Email/Phone
6
Repository SpecialistReveal Email/Phone
7
Fellow in External AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Aeras Global TB Vaccine Foundation?

The Aeras Global TB Vaccine Foundation is a non-profit Product Development Partnership (PDP) dedicated to the development of effective TB vaccine regimens that will prevent tuberculosis in all age groups and will be affordable, available and adopted worldwide.

keywords:N/A

N/A

Total Funding

76

Number of Employees

$11.8M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aeras Global TB Vaccine Foundation News

2022-03-22 - The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

I have been working on tuberculosis vaccine clinical development in my ... Gates Foundation (BMGF) and by Aeras, for the prevention of TB...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.3M7636%N/A
#2
$16M76-3%N/A
#3
$24.7M764%N/A
#4
$11M7627%N/A
#5
$15.7M783%N/A